Charged Alpha Stock Encyclopedia

The Procter & Gamble Company (PG) Q4 FY2026 — Q4 net sales were $21.203B (+2%, a miss vs ~$21.38B); core EPS of $1.43 matched consensus but fell 3%, and currency-neutral core EPS fell 5%. Organic sales growth was 0% — volume 0%, pricing 0%, mix 0% — so all the reported growth was currency and rounding. GAAP EPS fell 15% to $1.26; core operating margin fell 130bps even with 460bps of gross productivity savings, because 410bps went back out as marketing reinvestment. Full year: net sales $87.0B (+3%), organic +1% with 100% of it pricing and volume flat, core EPS $6.89 (+1%), currency-neutral core EPS growth 0%. FY2027 guidance: organic +1-3%, core EPS 0-3% (midpoint $7.00), a ~$1B after-tax commodity headwind, and Q1 guided to -5% or more.

P&G is the stock people own so they can stop worrying — but for the full year organic sales grew 1% and every point of it was price, with volume flat: in unit terms P&G sold exactly as much as the year before. Its own slide shows organic growth decelerating 7% to 4% to 2% to 1% across FY2023-FY2026, and currency-neutral core EPS growth going 16% to 4% to 0%. Share is going with it — P&G held or grew value share in only 26 of its top 50 category-country combinations, the weakest in the decade it publishes. FY2026 dividends plus buybacks were $15.26B against $15.15B of free cash flow, or 101%, and FY2027 commits ~$15B against roughly $14B of guided cash. Our owner-earnings DCF at a 7.0% required return lands at $134 vs $143.55, and the reverse DCF says the price requires ~3.8% annual growth from a business delivering 1%. Our call: AVOID, 2/5 — a price problem, not a quality problem. Wall Street is still Buy at a ~$158.56 average target, so we DIFFER.

THE CALL: AVOID (2/5, A 1% COMPOUNDER PRICED FOR A 4% ALGORITHM — GREAT COMPANY, WRONG PRICE) — base-case value ~$134.00 vs ~$143.55 today.

What to watch: organic VOLUME turning positive and staying positive — two consecutive quarters of real unit growth with core operating margin expanding would rebuild the algorithm case, and a recovery in the top-50 share count from 26 toward the low thirties would confirm it; the risk is the opposite — a fourth year below algorithm, further share loss, commodity costs past the guided $1B, or a buyback cut

Also on YouTube: @ChargedAlpha

DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

ASE Technology Holding Co., Ltd. (ASX) Q2 2026 — Revenue was NT$191,064M (about US$6.05B), +26.7% YoY and +10.0% QoQ — an all-time record. Gross margin rose to 21.0% from 20.0% and operating income of NT$21,134M was +107% YoY; net income was NT$21,068M vs NT$7,521M. Basic EPS NT$4.80 = US$0.304 per ADS vs consensus near US$0.23. CONVENTION: ASE reports in New Taiwan dollars, 1 ADS = 2 common shares, NT$31.59 = US$1. ATM (assembly and test) did NT$126,148M, +36.3%, at a 27.3% gross margin and 15.7% operating margin — both UP; EMS did NT$65,789M, +11.9%, at 8.9% gross and 2.4% operating — both DOWN. ATM is 66% of revenue and 93.6% of operating income. Testing revenue grew 42.5%, faster than packaging's 34.9%, and computing rose to 30% of ATM revenue from 24%. But free cash flow was MINUS NT$32,835M (about −US$1.04B) on NT$79,849M of cash capex against NT$47,014M of operating cash flow, funded with NT$39,864M of new borrowings as net debt/equity went 0.40 to 0.47.

Two things trip everyone up: this is ASE Technology Holding (NYSE: ASX, Taipei 3711), NOT the Australian stock exchange; and one ADS equals TWO common shares at NT$31.59/US$1, so NT$4.80 of EPS is 30.4 US cents per ADS, not 15. ASE is two companies in one ticker — ATM, the real semiconductor business, expanded gross margin to 27.3% while EMS fell to an 8.9% gross and 2.4% operating margin, so the blended 21.0% hides the good business. The AI leverage is measurable: computing went 24% to 30% of ATM revenue and testing grew 42.5%. The most under-covered number is the machine count — testers went 6,797 to 8,348 (+23%) while wirebonders SHRANK from 25,156 to 24,815, and US$804M of US$1,695M equipment capex went into testing. ASE is converting itself into a test house. But the headline capex understates the cash: actual PP&E payments were US$2.53B, 49% more, so free cash flow was about MINUS US$1.04B in the best quarter this company has ever had — funded with debt. We value it on owner earnings (operating cash flow less maintenance capex) of ~US$3.04B/yr, with capex split 31% maintenance / 69% growth. At an 11% discount rate: $16 if the cycle rolls over, $37 if AI packaging is secular, $24 mid case; a 12x FY26E EBITDA cross-check gives $28. We blend to ~$26 per ADS — still ~16% BELOW the $31.12 price even after a 32% drawdown from the June high of $45.52.

THE CALL: HOLD (3/5, A RECORD QUARTER, STILL PRICED FOR PERFECTION) — base-case value ~$26.00 vs ~$31.12 today.

What to watch: free cash flow turning positive while ATM revenue is still growing — the proof the capacity build pays for itself rather than being financed. We would also raise our number on ATM operating margin pushing through 18% (15.7% today), testing growth holding above 40%, or LEAP tracking above its US$3.5B 2026 guide. What breaks it is ATM gross margin flattening WHILE capex stays at this pace. Buyers again under about $24.

Also on YouTube: @ChargedAlpha

DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

Meta Platforms, Inc. (META) Q2 2026 — Meta Platforms (META) reported Q2 2026 (quarter ended June 30, 2026) after the close on July 29: revenue $60.80B, +28% YoY (+27% constant currency), a beat — but diluted EPS fell 13% to $6.18, missing the Street by roughly a dollar, and operating margin collapsed from 43% to 31%. Total costs and expenses rose 55% to $42.03B, including $2.40B of legal charges and $1.18B of severance from the May headcount reduction; R&D alone rose 67% to $21.66B (35.6% of revenue). The number that moved the stock: capex was $31.08B in a single quarter (51% of revenue), leaving free cash flow of just $784M, down 91% from $8.55B. Full-year 2026 capex guidance narrowed to $130-145B (vs $72B spent in 2025), implying $79-94B in H2 alone. Meta bought back ZERO stock in Q2 and zero in H1 (vs $22.9B in H1 2025) and instead issued $24.9B of long-term debt, taking total debt to $83.7B against $90.3B of cash and securities — net cash of only ~$6.6B, down from ~$23B six months ago. Stock comp was $7.66B, +58%, while headcount FELL 1% to 75,472 (~$406k of stock per employee annualized vs ~$254k a year ago). Under-covered angles: US & Canada is 44% of revenue and grew 31.6% with price per ad +20% on only +9% impressions (genuine pricing power), while Asia-Pacific price per ad grew just 1% and Europe just 10% (DMA pay-or-consent drag); Reality Labs lost $4.62B on $431M of revenue, a wider loss than last year and roughly $97B of cumulative operating losses since 2019; and D&A of $6.36B (a ~$25B annual run-rate) must eventually climb toward the $137B annual capex rate — if depreciation were already there, this quarter's $18.8B of operating profit would be about $2B. Our owner-earnings DCF (maintenance capex charged at $45B/yr, stock comp expensed, 10.5% discount rate) lands a probability-weighted fair value near $610 vs ~$527.34 in the July 30 pre-market (the pre-print close of $585.61 is the wrong basis — this printed AMC). Our call: BUY, 3/5. Wall Street's aggregate target is $724.50 (Buy, 65 analysts), but every analyst who updated after the print CUT: JPMorgan $640 (Neutral), UBS $715, Goldman $725, TD Cowen $750, Citi $800, BofA $810 — six cuts, zero raises, median ~$740. We AGREE on direction and DIFFER on value: our $610 sits below even the lowest fresh target.

Meta Platforms just printed one of the strangest quarters in mega-cap history: revenue accelerated to $60.80 billion, up 28% year over year — and free cash flow collapsed 91% to $784 million. Q2 2026 (ended June 30, 2026) delivered a revenue beat and a profit miss in the same release. Operating income fell 8% to $18.78 billion, diluted EPS fell 13% to $6.18, and operating margin dropped from 43% to 31%. Strip out the $2.40B of legal charges and $1.18B of severance and margin is still only ~36.8%, because R&D rose 67% to $21.66 billion — 35.6 cents of every revenue dollar. The line almost nobody leads with: Family of Apps operating income FELL 6% (to $23.39B) on revenue that grew 28%; the core ad franchise earned fewer absolute dollars. The cause is capital spending. Capex was $31.08 billion in one quarter — 51% of revenue — and full-year guidance narrowed to $130-145 billion, implying $79-94 billion in the second half alone, nearly double the first. Meanwhile depreciation and amortization is only $6.36 billion a quarter, a ~$25 billion annual run-rate against a ~$137 billion annual spend rate. That gap is the depreciation cliff: if depreciation were already where the spend rate implies, this quarter's $18.8B of operating profit would be roughly $2B. Three under-covered angles decide this stock. First, pricing power is real but concentrated: in the US & Canada — 44% of all revenue — price per ad rose 20% on just 9% more impressions, while Asia-Pacific price per ad rose 1% and Europe only 10% (the DMA pay-or-consent drag). Second, capital allocation reversed: Meta repurchased zero stock in Q2 and zero in H1 (vs $22.9B a year earlier) and issued $24.9 billion of long-term debt instead; net cash is down to ~$6.6 billion from ~$23 billion, and stock comp of $7.66 billion (+58%) on a headcount that FELL 1% works out to roughly $406,000 of stock per employee per year. Third, Reality Labs lost $4.62 billion on $431 million of revenue — a wider loss than a year ago, and roughly $97 billion of cumulative operating losses since 2019. Our valuation charges Meta harder than we charged Microsoft a day earlier, deliberately: Microsoft sells AI capacity to contracted customers, Meta's capacity serves Meta. We charge $45 billion a year of maintenance capex, expense the stock compensation, and still get about $80 billion of owner earnings — a probability-weighted fair value near $610 versus roughly $527 in the July 30 pre-market (the $585.61 pre-print close is the wrong basis; this reported after the close). At $527 the market is paying about 16.8x owner earnings, implying just ~6% annual growth for a decade from a company growing revenue 28%. Our call: BUY, 3 out of 5 — a modest 16% margin of safety, not a screaming one. Wall Street's aggregate target is $724.50 with a Buy consensus, but every single analyst who updated after this print cut their target — JPMorgan to $640, UBS $715, Goldman $725, TD Cowen $750, Citi $800, BofA $810, a median near $740. We agree on direction and differ hard on value: our $610 is below the lowest fresh target on the Street. Watch price per ad by region and 2027 capex guidance — those two lines decide everything. Not financial advice.

THE CALL: BUY (3/5, WE VALUE IT BELOW EVERY FRESH STREET TARGET — AND IT IS STILL CHEAP) — base-case value ~$610.00 vs ~$527.34 today.

What to watch: 2027 capital expenditure guidance coming in at or below 2026's level, free cash flow inflecting back above $10B a quarter, and the buyback restarting would each signal that the spending peak is behind Meta and would justify a higher fair value and an upgrade; the risks to respect are the mirror image — 2027 capex guided above roughly $170 billion, which means depreciation is chasing a target that keeps moving and never catches up, or US & Canada price per ad decelerating toward the Asia-Pacific pattern of flat pricing on more inventory, which would mean the AI spend is not actually buying pricing power at all

Also on YouTube: @ChargedAlpha

DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

Fortinet, Inc. (FTNT) Q2 2026 — Fortinet (FTNT) reported Q2 2026 (quarter ended June 30, 2026) after the close on July 29, 2026, in an 8-K under Item 2.02. Revenue was $2,047.9M, +25.6% YoY (from $1,630.0M) versus roughly $1,888M expected; non-GAAP diluted EPS $0.90 versus about $0.75 expected (+41% YoY, a ~20% beat) and GAAP diluted EPS $0.82 (+44%). GAAP operating income was $689.3M at a 33.7% margin, up 560bps from 28.1%; non-GAAP operating margin hit 38.0% from 33.1%. Billings — the metric that actually moves this stock — grew 33.4% to $2,372.1M, a 1.16x book-to-bill, as deferred revenue rose $324.2M in the quarter (versus $149.2M a year ago) to $7,675.7M in total. Free cash flow was $965.6M, a 47.2% margin versus 17.4% a year earlier, on operating cash flow of $1,043.6M (+131%) and capex of just $78.0M (versus $167.8M, of which $143.8M was real estate); adjusted free cash flow was $995.9M versus $427.9M. But the composition is the story: product revenue grew 51.9% to $773.0M while service revenue — 62.3% of the business and the actual annuity — grew only 13.7% to $1,274.9M. Product is just 37.7% of revenue yet delivered roughly 63% of all growth in the quarter, and it grew because the enormous 2020-2022 FortiGate installed base is hitting end-of-support. It is also the lowest-margin line (69.8% gross margin versus 86.6% on service) and the least recurring. The 560bp margin expansion was a cost story, not a demand story: revenue grew 25.6% while total operating expenses grew 11.3%, with R&D up only 7.4% to $225.0M — falling to 11.0% of revenue from 12.9%, remarkably low for a security platform in an AI arms race — and sales and marketing down to 32.7% of revenue from 36.3%. The quality of earnings is genuinely exceptional and almost never discussed: stock compensation was $80.8M, only 3.9% of revenue, so the entire GAAP-to-non-GAAP bridge is $0.08 on $0.90, while accounts receivable FELL 13.9% to $1,455.6M against 26% revenue growth. Fortinet repurchased $972.8M of stock in H1 and repaid $500M of senior notes (interest income consequently fell 26% to $33.2M), taking diluted shares down 4.2% YoY to 739.9M; Moody's upgraded the senior unsecured rating to A3 from Baa1, the highest of any public cybersecurity company. Guidance was raised: FY2026 revenue $8.020-8.180B (about +19%), service revenue $5.180-5.220B, billings $9.350-9.550B, non-GAAP operating margin 35-37% and non-GAAP EPS $3.41-3.47; Q3 revenue $2.010-2.100B with billings $2.250-2.350B, a clear step down in billings growth from the 33% just printed. The stock trades near $153.22 against a 12-month range of roughly $74 to $167 — up 106% off the low and 54% above its own 200-day average, with essentially the entire move made in the three months since the Q1 print. Our owner-earnings DCF, off an FY2026E free cash flow base of about $3.7B (a 46% cash margin, i.e. a cycle high) with $3.97B of net cash and ~743M diluted shares, gives $93 if the refresh fades and $146 if 'SASE Firewall' is a genuinely secular category, both at 9%; our probability blend is about $116, roughly 24% below the price. Our call: TRIM, 3/5 — an exceptional business whose growth engine has a date on it. Wall Street's aggregate is a Hold consensus at a $122.65 average target across 68 analysts (29 buy / 33 hold / 6 sell, range $80-$190), which is itself 20% BELOW the current price, though post-print revisions are running sharply higher (BofA to $200, TD Cowen to $215, Cantor to $165 Neutral, Morgan Stanley still Underweight at $80). So we are CAUTIOUS and we DIFFER — more conservative than the post-print scramble.

Fortinet just printed one of the cleanest quarters in cybersecurity — and we are trimming it. Q2 2026 (quarter ended June 30, reported after the close on July 29): revenue $2,047.9M, +25.6% YoY, against roughly $1,888M expected. Non-GAAP EPS $0.90 versus about $0.75 — a 20% beat, up 41%. GAAP EPS $0.82, up 44%. GAAP operating margin expanded 560 basis points to 33.7%; non-GAAP hit 38.0%. Billings, the metric that actually moves this stock, grew 33% to $2.37B. Free cash flow was $966M — a 47.2% margin, against 17.4% a year ago. Management raised the full year to $8.02-8.18B, about 19% growth, with billings guided as high as $9.55B. So why trim? Because of where the growth came from. Fortinet has two revenue lines. Service — subscriptions and support, the recurring annuity — is 62% of the business and grew 13.7%. Product, the physical FortiGate boxes, grew 51.9% to $773M. That single line is only 38% of revenue yet delivered about 63% of all the growth in the quarter, and it grew for a specific, datable reason: the enormous wave of appliances Fortinet sold from 2020 through 2022 is hitting end-of-support and customers have to replace it. It is also the lowest-margin line in the business, 69.8% gross margin against 86.6% on service. Strip product back to the annuity's growth rate and this 26% quarter is a 14% quarter. The margin expansion is a cost story too: revenue grew 25.6% while operating expenses grew 11.3%, and R&D rose just 7.4% to $225M — falling to 11.0% of revenue from 12.9%, remarkably lean for a security platform in an AI arms race. It flatters this quarter and mortgages 2029. Now the part almost nobody mentions, and it is genuinely bullish: the quality of these earnings is exceptional. Stock compensation was $80.8M, just 3.9% of revenue, so the entire gap between GAAP and non-GAAP earnings is eight cents on ninety — across most of security software stock comp runs 15-25% of revenue and non-GAAP profit is close to fiction. Receivables actually FELL 14% while revenue grew 26%. Deferred revenue rose to $7.68B. Management bought back $973M of stock in the first half, much of it while the shares sat between $75 and $90, and Moody's just upgraded Fortinet to A3 — the highest rating of any public cybersecurity company. This is a superb, founder-led, net-cash business. The problem is the price. At $153 the stock is up 106% from its 12-month low and trades 54% above its own 200-day average, with essentially the whole move made in three months. That is about 44x forward non-GAAP earnings and roughly 30x our FY26 free cash flow estimate — for most of last year the market paid about 30x trailing earnings for this same company, so the multiple re-rated at the same time as the earnings. Our owner-earnings DCF starts from an FY26 free cash flow base near $3.7B, which is itself a 46% cash margin and a cycle high. If the refresh fades, it is worth $93 a share at 9%. If 'SASE Firewall' is a genuinely durable new category, $146. Blending those and adding $3.97B of net cash, we land near $116 — about 24% below the price. Run it backwards and today's $153 requires free cash flow to compound at roughly 14.5% every year for five straight years off that already-elevated base. Even our generous secular case does not reach the current price, and when your bull case does not reach the market price you have no margin of safety. Our call: TRIM, 3/5 — buyers again under about $105. Wall Street's aggregate is a Hold with a $122.65 average target across 68 analysts, itself 20% below the price, but the post-print revisions are flying upward: BofA to $200, TD Cowen to $215, Cantor to $165 on Neutral, while Morgan Stanley stays Underweight at $80. We DIFFER and we are more cautious than that scramble. Watch billings and service growth every quarter — Q3 billings are guided to $2.25-2.35B, already a clear step down from 33%. They will settle this argument long before revenue does. Not financial advice.

THE CALL: TRIM (3/5, A GREAT COMPANY ON A CYCLE YOU CAN DATE) — base-case value ~$116.00 vs ~$153.22 today.

What to watch: we would turn more constructive on evidence the refresh is a land grab rather than a pull-forward — product revenue still growing in 2027 as it laps this +52%, service revenue growth accelerating above 15% as those newly shipped boxes attach subscriptions, and R&D intensity turning back up from 11.0% of revenue; any of those three and we would raise our number. What breaks the thesis is billings decelerating toward the low teens, and management has already guided Q3 billings to $2.250-2.350B, a clear step down from the 33% just printed; billings feed the deferred-revenue float that produced this quarter's 47% free-cash-flow margin, so they are the leading indicator that settles this argument long before revenue does. We would be buyers again under about $105.

Also on YouTube: @ChargedAlpha

DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

QUALCOMM Incorporated (QCOM) Q3 FY2026 — Qualcomm (QCOM) reported fiscal Q3 2026 (quarter ended June 28, 2026) after the close on July 29: revenue $9,947M, down 4% YoY but at the high end of its own guide; GAAP EPS $1.87 (-23%) and non-GAAP EPS $2.21 (-20%), a penny or two under the ~$2.23 consensus. The line that matters is below the revenue: GAAP operating income fell 41% to $1,626M, operating margin went from 26.6% to 16.3%, and gross margin slipped from 55.6% to 53.1% — because revenue fell 4% while R&D rose 17% and SG&A rose 27%. QCT did $8,504M (-5%) at a 26% EBT margin (was 30%); QTL licensing did $1,278M (-3%) at a 69% EBT margin. Inside QCT: handsets $5,086M (-20%), automotive $1,588M (+61%, a 23rd straight double-digit quarter), IoT $1,830M (+9%). On the call the CFO said Qualcomm's share of the next iPhone will be 'materially less' than the 20% previously guided and that Apple product revenue falls roughly 50% sequentially from the September to the December quarter, with FY27 Apple revenue below the ~$2B previously indicated. Q4 FY26 guide: revenue $9.7-10.5B, QCT $8.4-9.0B, QTL $1.2-1.4B, GAAP EPS $1.22-1.42, non-GAAP EPS $2.05-2.25 — with $0.72 of that gap being stock compensation. The stock closed at $155.68 on July 29 (already -4.4% that session) and traded around $146.21 in the July 30 pre-market.

Qualcomm (QCOM) is a two-headed business that most people value as one: QCT, which designs and sells Snapdragon chips into phones, cars, IoT and now data centre, and QTL, which licenses the patent portfolio at a 69% pre-tax margin. In fiscal Q3 2026 (quarter ended June 28, 2026) the company did $9,947M of revenue, down 4%, with non-GAAP EPS of $2.21 and GAAP EPS of $1.87 — but GAAP operating income fell 41% and gross margin dropped from 55.6% to 53.1%. Handset chips, still 51% of revenue, fell 20% under memory-price inflation; automotive grew 61% and IoT grew 9%. This episode pushes past the headline into three things almost nobody covered. First, the GAAP line was flattered: investment and other income was $1,014M versus $358M a year ago, including $726M of unrealised marks on equity securities, and Qualcomm's own reconciliation shows the QSI strategic-investments segment contributed $0.57 of the $1.87 — core GAAP earnings were nearer $1.30. Nine-month GAAP net income of $12.4B also contains a one-off, non-cash $5.7B tax benefit from releasing a deferred-tax valuation allowance, so any screener showing QCOM at ~7x trailing earnings is reading an accounting entry. Second, the concentration paradox: the 10-Q's unnamed 10%-plus customer table shows the largest customer going from 18% to 23% of revenue, the second holding at 20%, and a third that was 13% last year now below 10% — so as the fading customer leaves, the top two go from 39% to 43%. Qualcomm is selling a diversification story in a quarter where its customer base got measurably more concentrated. Third, the mix is margin-dilutive and management said so: QCT gross margin has fallen below its historical 48-50% band and the first wave of custom data-centre silicon will be 'significantly lower' margin, a 1.5-2 point drag on QCT's weighted average. So $40B of non-handset revenue by FY29 is not worth $40B of Snapdragon revenue. We value QTL and QCT separately, run an owner-earnings DCF that expenses the $3.4B of annual stock compensation instead of adding it back, and cross-check it with a reverse DCF. Our answer is contrarian, and we say so on the slide.

THE CALL: AVOID (2/5, REAL DIVERSIFICATION, BUT THE PRICE ALREADY PAYS FOR IT — AND STOCK COMP IS 8% OF REVENUE) — base-case value ~$$122 vs ~$$146.21 today.

What to watch: a data-centre gross margin that turns out better than management's 'significantly lower', QCT margin returning inside the 48-50% band as the double-digit price increases land, and a third and fourth hyperscaler signing after the High Bandwidth Compute silicon demos, would all change the terminal maths and could move us up — the risks to respect run the other way: QTL is a ~$3.5B pre-tax annuity with genuine renewal risk and a licensee base under permanent legal and regulatory pressure, inventory sits at $8.38B (+28% since September, ~164 days of cost of revenue) into a memory price spike that could reverse into a write-down, net debt is now ~$7.0B where this used to be a net-cash balance sheet, and stock compensation grew 25% year over year while revenue fell 4%.

Also on YouTube: @ChargedAlpha

DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

Microsoft Corporation (MSFT) Q4 FY2026 — Microsoft (MSFT) reported fiscal Q4 2026 (quarter ended June 30, 2026) after the close on July 29, 2026, alongside its FY26 10-K. Revenue was $90.007B, +18% YoY (+17% constant currency) versus roughly $87.6B expected; GAAP diluted EPS $4.81 (+32%) and adjusted EPS $4.74 versus about $4.24 expected; operating income $40.6B (+18%) at a 45.1% margin. Azure and other cloud services grew 43% (43% cc), accelerating from 39/40/39/40 in the four prior quarters, and Azure crossed $100B of annual revenue for the first time. Microsoft Cloud revenue was $59.3B (+27%) but its gross margin fell to 65% — a fourth consecutive quarterly decline from 68%, which management attributes to sales mix shift to Azure and continued AI infrastructure investment. Commercial remaining performance obligation reached $678B (+84%; +25% excluding OpenAI) with a 2.3-year weighted-average duration. Microsoft 365 Copilot passed 30 million paid seats (from 15M two quarters ago) while M365 commercial seat growth stayed at +6% for a sixth straight quarter — so Copilot is ARPU, not seats. For the full fiscal year: revenue $331.8B (+18%), operating income $155.2B (+21%) at a 46.8% margin (+120bps), GAAP EPS $17.95 (+32%). The problem is cash: FY26 cash additions to property and equipment were $115.9B plus $24.6B of finance-lease additions (~$140.6B, 42.4% of revenue versus 22.9% in FY24), so free cash flow fell for a third straight year to about $67.0B (from $71.6B and $74.1B) and Q4 free cash flow dropped 23% to $19.6B. Leases signed but not yet commenced jumped from $92.7B to $329.1B. Depreciation is up 126% in two years to $34.3B. Microsoft funded all of it with zero new debt, drawing cash down 18.7% to $76.8B, lifting finance-lease liabilities 44% to $66.6B and stretching unpaid capex in payables by $19.8B to $26.7B. Return on invested capital fell from about 24.5% to 22.8% as invested capital grew 26.9% against 18.1% NOPAT growth. The quarter's beat also included a $3.2B Anthropic gain that is not mentioned once in the 10-K, and the FY27 extension of data-centre and office-building useful lives from 15 to 25 years was disclosed only on the call. The stock closed at $390.54 (-0.71%) on July 29 before the print and traded at $425.01 (+8.83%) in the after-hours session at 7:59pm ET. Our owner-earnings DCF — operating cash flow less expensed stock comp less a maintenance-capex charge of about $52.8B — lands at a base case near $385 at a 9% discount rate (bear $232, bull $497), so $425.01 is roughly 9% above our value; the reverse DCF says today's price requires owner earnings to compound near 10% a year for five years against our ~7%. Our call: HOLD, 3/5 — an A-grade franchise at a price that needs the AI capex to work. Wall Street is at a BUY consensus with a ~$538 average target (66 buy / 16 hold / 0 sell, 82 analysts, all dated on or before July 28 and therefore pre-print), implying about +27%, so we DIFFER and are materially more cautious.

Microsoft just printed the best quarter in its history — and its stock spent the previous twelve months falling. Fiscal Q4 2026 (quarter ended June 30, 2026, reported after the close on July 29): revenue $90.007B, +18% YoY and +17% in constant currency, against roughly $87.6B expected. GAAP diluted EPS $4.81, up 32%; adjusted EPS $4.74 versus about $4.24 expected. Operating income $40.6B, +18%, at a 45.1% margin. Azure grew 43% — accelerating from 39, 40, 39 and 40 in the four prior quarters — and crossed $100 billion of annual revenue for the first time, with management stating plainly that customer demand continues to exceed supply. The contracted commercial backlog hit $678B, up 84%, and still up 25% excluding OpenAI. Microsoft 365 Copilot passed 30 million paid seats, tripling in three quarters, while M365 commercial seat growth stayed pinned at +6% for a sixth straight quarter — the Copilot story is ARPU, not seats. For the full year: revenue $331.8B (+18%), operating income $155.2B (+21%), operating margin 46.8% (+120bps), GAAP EPS $17.95. So why did the market cap fall 25% across fiscal 2026? One line: cash. Microsoft spent $115.9B of cash on property and equipment plus $24.6B of finance leases — about $140.6B, or 42.4% of revenue, up from 22.9% two years ago — and free cash flow fell for a third consecutive year to roughly $67.0B, with Q4 free cash flow down 23%. Microsoft Cloud gross margin has now fallen four quarters running, 68% to 65%, for reasons management itself calls structural: mix shift to Azure and continued AI infrastructure investment. Depreciation is up 126% in two years. Leases signed but not yet commenced went from $92.7B to $329.1B. Return on invested capital slipped from ~24.5% to ~22.8% because invested capital grew 27% while operating profit after tax grew 18% — the first time at this scale that Microsoft is compounding capital faster than profit. We also flag two disclosure issues: the $3.2B Anthropic gain inside the earnings beat is not mentioned once in the 10-K, and the FY27 extension of building useful lives from 15 to 25 years — which also reclassifies future data-centre leases out of the capex line — was spoken on the call only. Our owner-earnings DCF (operating cash flow, less expensed stock comp, less a ~$52.8B maintenance-capex charge reflecting what it costs to replace a $432B gross asset base) lands at a base case near $385 per share at 9%, with a bear case of $232 and a bull case of $497 if six-year server lives hold and the fleet really is pre-sold. The stock closed at $390.54 the afternoon it reported — within 1.5% of our number — then traded at $425.01 after hours, about 9% above it. Run the DCF backwards and $425 requires owner earnings to compound near 10% a year for five years; our work says about 7%. Our call: HOLD, 3/5. The franchise grades an A; the price does not. We would be buyers back under about $350. Wall Street is overwhelmingly bullish — a BUY consensus, 66 buys against 16 holds and no sells, average target near $538, every one of those targets published on or before July 28 and therefore pre-print — so we DIFFER, and materially. Watch free cash flow, Microsoft Cloud gross margin, and return on invested capital every quarter; they will settle the argument. Not financial advice.

THE CALL: HOLD (3/5, THE BEST QUARTER IT HAS EVER PRINTED — AT A PRICE THAT NEEDS THE AI CAPEX TO WORK) — base-case value ~$385.00 vs ~$425.01 today.

What to watch: the free-cash-flow line inflecting would turn us more constructive — capital spending flattening while Azure holds above 40% growth, which would reverse three years of falling free cash flow almost immediately; that is not imminent, since management guided capex over $50 billion for Q1 FY2027 and growing for the full year; the risks to respect are the opposite — Microsoft Cloud gross margin slipping below 63%, Azure decelerating into the mid-thirties, or a fourth consecutive year of falling free cash flow, and note that management's only FY2027 cash commitment is that Microsoft will remain free-cash-flow positive, a strikingly low bar for this company

Also on YouTube: @ChargedAlpha

DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

Lam Research Corporation (LRCX) Q4 FY2026 — Lam Research (LRCX), one of the four indispensable wafer-fab equipment makers alongside ASML, Applied Materials and KLA, reported fiscal Q4 2026 (quarter ended June 28, 2026) after the close on July 29: revenue $6.722B (+30.0% YoY, +15.1% QoQ), GAAP diluted EPS $1.81 and non-GAAP $1.82 (vs $1.68 consensus), GAAP gross margin 51.7% and operating margin 37.4% — records on essentially every line and above the high end of guidance. The real news was the guide: September-quarter revenue of $8.10B +/- $400M against a ~$7.09B consensus, with EPS of $2.15 vs $1.83 expected, gross margin 52.0% and operating margin 39.5% — above the top of Lam's own prior long-term model. FY2026: revenue $23.233B (+26.0%), net income $7.265B (+35.6%), diluted EPS $5.76. Under-covered: CSBG (installed-base spares/service on 100,000+ chambers) grew 42.6% YoY to $2.472B, FASTER than systems (+23.6%), and is now ~37% of revenue; China collapsed from 34% of revenue in March to 26% in June, with China dollars actually DOWN ~12% sequentially while total revenue rose 15% — every dollar of sequential growth came from outside China (Taiwan is now #1 at 27%); and FY26 free cash flow FELL 9.7% to $4.891B even as net income rose 36%, as receivables jumped 58% YoY and DSO stretched from 59 to 72 days, dropping cash conversion from 101% to 67%. Credit where due: Lam does NOT add back stock compensation — non-GAAP EPS $1.82 vs GAAP $1.81, a one-cent gap — and management cut buybacks to $247M in the June quarter (from $1.16B at ~$211/sh in March) while the stock made all-time highs above $430. Our normalized owner-earnings DCF on $9.3B of mid-cycle owner earnings (mid-cycle revenue $30B at a 37% operating margin, 9% discount, 3.75% terminal) lands fair value at $184 vs $264.30 after hours on July 29 — the price sits ~44% above value, ~30% downside. The reverse DCF says $264.30 requires ~11% owner-earnings growth every year for a decade, implying ~$80B of revenue by 2036 against a total WFE market of ~$140B today. Our call: AVOID, 4/5 — a superb business at a price that capitalizes the peak. Wall Street is at a $372.76 average target (39 buy / 10 hold / 1 sell), so we DIFFER sharply.

Lam Research (LRCX) just printed the best quarter in its history and then guided even higher — and we still think you should avoid the stock at this price. That tension is the whole episode. Fiscal Q4 2026 (quarter ended June 28, 2026, reported after the close July 29): revenue $6.722B, up 30% YoY and 15% sequentially; GAAP diluted EPS $1.81, non-GAAP $1.82 against a $1.68 consensus; GAAP gross margin 51.7% and operating margin 37.4% — records, all above the high end of guidance. Then management guided the September quarter to $8.10B +/- $400M versus a ~$7.09B consensus, with EPS of $2.15 vs $1.83 expected and a 39.5% operating margin that sits above the top of Lam's own long-term model. Full-year FY2026 revenue was $23.233B (+26%) with net income of $7.265B (+36%) and diluted EPS of $5.76. We push past the headline into three things almost nobody covered. First, the Customer Support Business Group — spares, service and upgrades across an installed base of more than 100,000 process chambers — grew 42.6% YoY to $2.472B, FASTER than the systems business at +23.6%, and is now nearly 37% of revenue; though we're honest that CSBG also contains Reliant trailing-edge tools, so it isn't a pure annuity. Second, China fell from 34% of revenue to 26% in a single quarter, and in absolute dollars China revenue DECLINED about 12% sequentially while total revenue rose 15% — meaning every dollar of sequential growth came from outside China, with Taiwan now the largest region at 27%. The export-control and local-competition bear case has largely already been absorbed: China was 42% of revenue in FY2024. Third, and least discussed, free cash flow went backwards: FY26 FCF fell 9.7% to $4.891B while net income rose 36%, because receivables jumped 58% YoY against 30% revenue growth, pushing DSO from 59 to 72 days and consuming $1.9B of cash. Cash conversion dropped from 101% of earnings to 67% — which is why the stock trades at 46x trailing GAAP earnings but 68x trailing free cash flow. Two things deserve genuine credit: Lam fully expenses stock compensation (non-GAAP EPS $1.82 vs GAAP $1.81 — a one-cent gap, with only intangible amortization reconciling), and management cut buybacks to $247M in the June quarter from $1.16B at roughly $211/share in March, refusing to chase all-time highs above $430. On valuation we normalize explicitly rather than capitalizing a record: mid-cycle revenue of $30B at a 37% operating margin, taxed at 13%, plus D&A less maintenance capex and a working-capital drag, gives $9.3B of mid-cycle owner earnings, or $7.43 per share. At a 9% discount rate with 6.5% growth for a decade and a 3.75% terminal rate, our base case is $184 (bear $127, bull $252). Against $264.30 after hours on July 29 — versus a $252.35 pre-print close, itself 42% below the June 30 closing high of $433 — the price sits about 44% above our value, roughly 30% downside. The reverse DCF is the sharper number: $264.30 requires ~11% owner-earnings growth every year for ten straight years off that mid-cycle base, taking owner earnings to ~$27B by 2036 and implying roughly $80B of revenue, about 3.5x FY2026, when the entire wafer-fab equipment market today is around $140B. Not impossible — but it prices the bull case as the base case with no down year in a decade, in an industry that has never gone a decade without one. Our call: AVOID, 4/5. This is a price objection, not a business objection. Wall Street's average target is $372.76 with 39 buys and one sell, so we DIFFER sharply — and we note most of those targets were set while LRCX traded between $300 and $438. Not financial advice.

THE CALL: AVOID (4/5, AN EXCELLENT BUSINESS AT A PRICE THAT CAPITALIZES THE PEAK — A VALUATION CALL, NOT A BUSINESS CALL) — base-case value ~$184.00 vs ~$264.30 today.

What to watch: free cash flow catching back up to earnings — days-sales-outstanding heading back toward 60 from 72 and cash conversion recovering from 67% toward 100% — plus the $40B NAND conversion wave actually landing in systems revenue rather than remaining optionality at ~12% of systems, and a long-term financial model update that makes 39.5% operating margins look structural rather than peak, would move us up materially; a price in the $180s reaches our base value and the $150s would be compelling at roughly 20x mid-cycle owner earnings; the risk to respect is the opposite — a single memory digestion quarter, a renewed China export-control tightening against a region still worth over $1.7B a quarter, or receivables stretching further, any of which hits a stock carrying no valuation cushion at 46x trailing earnings

Also on YouTube: @ChargedAlpha

DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

Arm Holdings plc (ARM) Q1 FY2027 — Arm Holdings (ARM), the UK-based company whose CPU architecture sits inside almost every smartphone on earth and a fast-growing share of AI data centers, reported fiscal Q1 2027 (quarter ended June 30, 2026) after the close on July 29: revenue rose 22% YoY to a record $1,289M, beating the $1.26B guide; royalty revenue +22% to $715M with data-center royalties more than doubling; license and other revenue +23% to $574M. Non-GAAP EPS of $0.45 (+29% YoY) beat both the $0.40 guide and the $0.40 Street estimate, and non-GAAP operating margin rose to 41.2%. Management raised Q2 guidance to $1.38B +/- $50M (Street ~$1.34B) and non-GAAP EPS to $0.47 +/- $0.04 (Street ~$0.43). But the GAAP books tell a different story: GAAP operating income was just $91M and the GAAP operating margin FELL to 7.1% from 10.8%, because Arm expensed $343M of share-based compensation plus $90M of employer taxes — 33.6% of revenue — in a single quarter. Of $270M GAAP net income, $128M was a non-cash equity-investment mark-up and $17M a tax benefit. Arm touts $1,397M of TTM non-GAAP free cash flow (+134%), but that treats $1,154M of TTM stock comp as free; subtract it and true owner free cash flow is roughly $243M, and on that basis Arm's FCF was negative in FY2024, FY2025 and FY2026. Annualized contract value rose only 13% versus reported licensing +23%, and Arm quietly stopped disclosing remaining performance obligations, Access licence counts and chip unit volumes. 30% of revenue ($388M) is related-party, principally Arm China. The stock closed at $224.89 on July 29 (down 8.1% on the day, pre-print) after a 50% collapse from its $452.70 June high, and traded near $225.84 after hours — essentially flat on a beat and raise. Our owner-earnings DCF with SBC honestly expensed lands at $66 (bear $28 / bull $105); the reverse DCF says today's price demands 37%/yr FCF growth for a decade on the company's own numbers, or 56%/yr with SBC expensed. Our call: SELL, 4/5 — a genuinely great business at a price we cannot defend. Wall Street is a Buy with a $318 average target (+41%), so we DIFFER, dramatically.

Arm Holdings (ARM) just did something unusual: it printed a record quarter, beat on both lines, raised guidance — and the stock barely moved, because it had already fallen 50% in six weeks. Arm is the UK-domiciled company that designs the CPU architecture inside almost every phone on earth and, increasingly, inside every AI data center; it licenses that IP up front and then collects a royalty on every chip that ships, forever. Fiscal Q1 2027 (ended June 30, 2026): revenue +22% YoY to a record $1,289M, above the $1.26B guide; royalty revenue +22% to $715M with data-center royalties more than doubling and Neoverse passing 1.5 billion cumulative cores (the first billion took six years, the most recent 500 million took nine months); license and other revenue +23% to $574M. Non-GAAP EPS $0.45 beat the $0.40 guide and the Street's $0.40, non-GAAP operating margin improved to 41.2%, and Q2 guidance was RAISED to $1.38B +/- $50M and $0.47 +/- $0.04 — both above consensus. Demand for the brand-new Arm AGI CPU (Arm's own production silicon, launched in March) now exceeds $2B across FY27-FY28 versus the $1B management guided in May, with foundry capacity, not orders, as the binding constraint. So why are we cautious? Because of the second set of books. GAAP operating income was only $91M and the GAAP operating margin actually FELL, from 10.8% to 7.1% — Arm expensed $343M of share-based compensation plus $90M of employer taxes, 33.6% of revenue, and non-GAAP adds every dollar back. Of $270M GAAP net income, $128M was a non-cash mark-up on equity investments and $17M a tax benefit. Arm reports $1,397M of TTM non-GAAP free cash flow, up 134% — but that treats $1,154M of stock handed to employees over the same twelve months as costless; diluted shares rose to 1,078M. Subtract it and true owner free cash flow is about $243M, and by fiscal year, after expensing stock comp, Arm's free cash flow was negative in FY2024, FY2025 AND FY2026. Three more things almost nobody mentions: annualized contract value grew only 13% while reported licensing grew 23%, so this quarter's licensing line borrowed from the future; Arm stopped reporting remaining performance obligations, Access licence counts and chip unit volumes, so nobody outside can verify the 'higher royalty rate per chip' claim; and $388M — 30% of all revenue — is related-party revenue, principally from Arm China, an entity Arm does not control. Add the strategic tension of Arm now selling silicon in competition with the licensees who pay it royalties (Qualcomm, a former litigation opponent, just announced its own Arm-based data-center CPU), a 98% gross margin that cannot survive a hardware mix shift, capex already running $197M a quarter (+28%), RISC-V at the low end, and SoftBank's ~88% stake leaving a ~12% float on a $240B company. Our owner-earnings DCF, with SBC expensed as the real cost it is (22%-to-13% revenue CAGR, owner cash margin scaling from 4.7% to 26%, 9.5% discount, 3.5% terminal growth), lands at $66 versus $225.84 after hours — 71% below. Even a deliberately generous bull case reaches only ~$105, which is BELOW the market price. Inverted, the reverse DCF says today's price requires ~37% annual free-cash-flow growth for ten straight years on the company's own definition, or ~56% with stock comp expensed; revenue grew 22%. Our call: SELL, 4/5 — the franchise is an A, the price is indefensible, and a 50% crash took Arm from absurd to merely very expensive. Wall Street is a Buy (19 buy / 6 hold / 2 sell) with a fresh $318 average target implying +41%, so we DIFFER dramatically. Watch owner free cash flow, not the non-GAAP headline. Not financial advice.

THE CALL: SELL (4/5, A GENUINELY GREAT BUSINESS AT A PRICE WE CANNOT DEFEND — EVEN AFTER A 50% CRASH) — base-case value ~$66.00 vs ~$225.84 today.

What to watch: share-based compensation falling from 27% of revenue toward the low teens while revenue keeps compounding above 20% would close the gap between reported and owner free cash flow faster than anything else in the model, and would move our fair value more than any other single assumption — that, plus a price somewhere between $100 and $130, would flip us constructive; the risks to respect run the other way — the blended gross margin compressing as Arm AGI CPU silicon mixes into a business that has never paid a foundry, capex and inventory building, annualized contract value continuing to lag reported licensing, further reductions in disclosure, or any SoftBank sell-down into a float of only about 12%

Also on YouTube: @ChargedAlpha

DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

General Dynamics Corporation (GD) Q2 2026 — General Dynamics (GD), the maker of Virginia- and Columbia-class submarines, Abrams tanks, GDIT government IT services and Gulfstream business jets, reported Q2 2026 (quarter ended July 5, 2026) before the open on July 29: revenue $14.094B (+8.1% YoY, beating the ~$13.52B consensus) and diluted EPS $4.24 (+13.4%) versus $3.96 expected — a 28-cent beat, with revenue growth in all four segments. Operating margin expanded 40 bps to 10.4%; operating earnings rose 11.9% to $1.46B. Total backlog hit a record $136.5B, up 31.6% YoY, with records in every segment and a 1.4-to-1 company book-to-bill on $20B of orders. Operating cash flow was $1.88B, or 162% of net earnings; cash nearly doubled to $4.33B and net debt fell to $3.18B from $5.68B at year-end. On the call management raised FY26 guidance to $16.80-$16.90 EPS on ~$55.7B revenue at a ~10.5% margin. And the stock still fell: GD opened at $397.40, touched a record $398.96 intraday, then reversed to about $380.96, down 3.1% from Tuesday's $393.19 close. Our read on why: the $0.35 guidance raise is barely more than the $0.28 quarterly beat, so the second half was lifted only ~$0.07, and $55.7B implies second-half revenue growth of just +2.9% versus +9.1% in the first half. Aerospace (Gulfstream) produced $107M of the $155M increase in operating earnings — 69% of the profit growth from the most cyclical business GD owns — on 41 aircraft deliveries versus 38. Combat Systems, the segment tied to European rearmament, grew revenue 0.3% with operating earnings down 1.9%, even as its backlog rose 77%. And 24% of the record backlog ($32.4B) is unfunded. Our owner-earnings DCF (GAAP net earnings + D&A - capex, stock comp left in as a real expense) puts normalized owner earnings near $4.3B, or $15.72/share, and lands a base fair value of ~$360 at an 8.5% discount rate versus $380.96 today. The reverse DCF says the current price requires 9% annual owner-earnings growth for five years, then 5.5% — above the 5.9% revenue growth GD itself just guided. Our call: HOLD, 3/5 — an excellent quarter from an excellent company at a price that already pays for it. Wall Street rates GD a Buy (18 buy / 15 hold / 1 sell) with a ~$415 average target implying +9%, so we DIFFER and are the cautious side; note that not one Street target had been refreshed after this print, and the freshest was Jefferies' $440 from July 9.

General Dynamics (GD) did almost everything right in Q2 2026 and the stock fell 3% anyway — and that reaction is the most interesting thing in the quarter. GD is really four companies in one ticker: Marine Systems (33% of revenue, Virginia- and Columbia-class submarines at Electric Boat and Bath Iron Works), Technologies (26%, GDIT plus Mission Systems), Aerospace (25%, Gulfstream business jets) and Combat Systems (16%, Abrams tanks, Stryker vehicles, munitions and European land systems). Q2 2026 (ended July 5, 2026): revenue $14.094B (+8.1%, a ~$570M beat), diluted EPS $4.24 (+13.4%) versus $3.96 expected, operating margin +40 bps to 10.4%, and growth in all four segments. Total backlog set a record at $136.5B, up 31.6%, with records in every segment and a 1.4-to-1 book-to-bill on $20B of orders. Cash flow looked spectacular: $1.88B of operating cash flow, 162% of net earnings, cash up to $4.33B and net debt down to $3.18B. Management then raised FY26 guidance to $16.80-$16.90 on ~$55.7B of revenue. So why did GD open at $397.40, print a record $398.96, and close the morning near $380.96? Three things the headlines skipped. First, the guidance arithmetic: the midpoint went up $0.35 against a $0.28 quarterly beat, so the second half was raised roughly $0.07, and $55.7B implies +2.9% second-half revenue growth versus +9.1% in the first half. Second, the mix: Aerospace is only a quarter of revenue but delivered $107M of the $155M operating-earnings increase — 69% of the profit growth came from business jets, the single most cyclical thing GD owns — on 41 Gulfstream deliveries versus 38 and a 1.5x Aerospace book-to-bill. Meanwhile Combat Systems, the European-rearmament segment, grew revenue 0.3% with earnings down 1.9% even as its backlog rose 77%: the rearmament trade is showing up in the order book and the multiple, not the income statement. Third, that 162% cash conversion is partly customer money — funded backlog jumped from $83.9B to $104.1B, and customers advance cash for submarines and jets not yet built; working capital that swings in eventually swings back out. And the tell: GD repurchased only $319M of stock in the first half against $600M a year ago, while the shares hit a record. Credit where it's due — GD reports GAAP EPS only, with no adjusted-EPS figure at all, and stock compensation is roughly 0.4% of revenue, which is why our owner-earnings framework is the honest one here: guided net earnings ~$4.62B, plus ~$0.93B of D&A, less ~$1.25B of capacity-expansion capex, equals ~$4.3B of owner earnings, or $15.72 a share. Discounted at 8.5% with 8% growth for five years then 5% for five more, that is $358; probability-weighted across conservative, base and bull cases, ~$360 versus $380.96 today. Run it in reverse and today's price demands 9% annual owner-earnings growth for five years — above the 5.9% revenue growth GD just guided. Our call: HOLD, 3/5. We would be buyers in the low $300s where there is a real ~15% cushion; up here there is none. Wall Street is at Buy with a ~$415 average target (+9%), so we DIFFER and we are more cautious — and note that not a single Street target was refreshed after this print, with the freshest being Jefferies' $440 from July 9. Watch Marine Systems margin (7.3% today; above 8.5% and the bear case largely dissolves), Combat Systems finally converting that 77% backlog growth, Gulfstream order flow, and whether those customer advances reverse. Not financial advice.

THE CALL: HOLD (3/5, AN EXCELLENT QUARTER FROM AN EXCELLENT COMPANY, AT A PRICE THAT ALREADY PAYS FOR IT) — base-case value ~$360.00 vs ~$380.96 today.

What to watch: Marine Systems operating margin sustained above 8.5% (it is 7.3% today, on a $65.2B backlog, and every hundred basis points is worth roughly 45 cents of annual EPS), Combat Systems finally converting its 77% backlog growth into actual revenue, and Technologies margin stabilizing above 9.5% — any two of those and our base value moves toward $400 and this becomes a buy at a higher price; the risks to respect are the mirror image — a Gulfstream order slowdown, since business jets produced 69% of this quarter's profit growth and are the most cyclical thing GD owns, a shipyard labor or fixed-price charge in Marine, a federal contracting slowdown hitting GDIT recompetes, and the reversal of the customer advances that flattered cash flow to 162% of net earnings

Also on YouTube: @ChargedAlpha

DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

Fortrea Holdings Inc. (FTRE) Q2 2026 — Fortrea (FTRE), the CRO spun out of Labcorp in 2023, reported Q2 2026 revenue of $678.2M (beating the $660.4M consensus but DOWN 4.5% from $710.3M a year ago), adjusted EBITDA of $58.7M at an 8.7% margin versus 7.7%, and adjusted EPS of $0.23 against a $0.19 estimate - while posting a GAAP net loss of $(13.2)M, or $(0.14) per diluted share. The bridge between those two numbers is $35.9M of add-backs: $14.6M amortization, $12.6M stock-based compensation (55% of the reported adjusted net income), $7.7M of 'other', $3.5M restructuring and a fourth year of 'one-time' spin costs. Operating income was $14.8M - a 2.2% margin - against $19.3M of interest expense, leaving a pre-tax LOSS of $(1.2)M, on which the company still recorded $12.0M of tax. Net debt is $885.7M, or 4.2x trailing adjusted EBITDA of $210.4M; TTM interest of $84.2M eats 40% of it. Guidance was raised to $2,620-2,690M of revenue and $205-220M of adjusted EBITDA, and the stock has run from $5.27 to $20.40 - within a dollar of its 52-week high. Our call: AVOID, 3/5, fair value $15.30.

Fortrea just beat Wall Street by four cents a share, raised full-year guidance, and reported a net loss. All three are true, and the distance between them is $35.9 million. Q2 2026 revenue of $678.2 million beat the $660.4 million consensus but is down 4.5% from a year ago. Adjusted EBITDA of $58.7 million and an 8.7% margin (versus 7.7%) are real progress - SG&A fell 18.2% year over year and gross margin widened on falling revenue. But GAAP operating income was only $14.8 million, a 2.2% margin, against $19.3 million of interest expense: this company paid its lenders more than it earned from running the business, reported a pre-tax loss of $1.2 million, and still recorded $12.0 million of income tax expense - which is how you get to a $13.2 million GAAP net loss. The $0.23 of adjusted EPS requires adding back $12.6 million of stock compensation, 55% of the adjusted net income itself. Net debt of $885.7 million is 4.2x trailing adjusted EBITDA, first-half free cash flow was NEGATIVE $5.1 million, receivables and unbilled services rose $64.7 million in six months while revenue fell, and tangible book value is about negative $1 billion. The stock has gone from $5.27 to $20.40. Our model says $15.30.

THE CALL: AVOID (3/5, A REAL TURNAROUND, ALREADY PAID FOR TWICE OVER) — base-case value ~$15.30 vs ~$20.40 today.

What to watch: Two consecutive quarters of clearly positive free cash flow with receivables and unbilled services growing slower than revenue - that would show the margin gains converting into cash rather than into unbilled balances - plus net leverage under 3.5x. Either would raise our multiple; both together and the equity re-rates on its own arithmetic. The near-term risk to respect is cash conversion: Q2 free cash flow was +$19.9M but the first half was -$5.1M, and receivables plus unbilled services climbed $64.7M in six months while revenue fell. If that repeats in Q3, the margin story and the cash story are pointing in different directions - and the cash story is the one that pays the $84.2M of annual interest.

Also on YouTube: @ChargedAlpha

DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.